LINC00682

Across TCGA pan-cancer cohorts, LINC00682 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of LINC00682’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC00682 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC00682 is over-expressed in tumor, although a few such as COAD and STAD show the opposite, repressed pattern.

COAD, STAD, and PAAD are the cancer types where LINC00682 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00682 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	II,III,IV	−0.494	<.001	11	view →
STAD	All	All	−0.186	.001	6	view →
PAAD	All	All	−0.055	<.001	6	view →
READ	Female	All	−0.798	<.001	3	view →
KICH	Male	All	+0.019	<.001	3	view →
LUAD	All	All	+0.145	.011	2	view →
LIHC	All	All	+0.020	.034	1	view →
THCA	Female	All	−0.011	.031	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

LINC00682–COAD

Open the COAD breakdown →